Aspirin and clopidogrel are anti – platelet drugs through different mechanisms through different mechanisms. The use of aspirin for the emergency treatment of heart attacks had shown previously, the risk for death and repeat heart attacks by about one quarter. The aim of the COMMIT/CCS-2 was to see whether adding clopidogrel to aspirin might be even better than aspirin alone.
COMMIT/CCS-2 aimed to determine whether orally, by intravenous metoprolol during a heart attack could then reduce deaths and. Risk of repeat heart attacks and cardiac arrest.. The study also found that what the beta-blocker metoprolol as an emergency treatment for heart attack reduces the risk of recurrence of myocardial infarction and ventricular fibrillation. Throws early use of beta – blocker treatment, the risk of cardiac shock in the period immediately after a heart attack, and early early benefits and hazards rather mutually exclusive.
Beta-blockers are proven effective long-term treatment in the years after a heart attack. But it is their value as emergency treatment and unsafe such use is limited, although current guidelines advise prompt administration contraindications contraindications. Continue reading “The use of aspirin for the emergency treatment of heart attacks had shown previously.”